<DOC>
	<DOCNO>NCT02288234</DOCNO>
	<brief_summary>The telavancin observational use registry ( TOUR ) collect data support study efficacy , safety , pattern use telavancin hospital-based inpatient outpatient treat infusion center receive clinician direct telavancin therapy .</brief_summary>
	<brief_title>Telavancin Observational Use Registry ( TOUR )</brief_title>
	<detailed_description>This retrospective medical chart review , multicenter , observational study examine telavancin efficacy safety real-word set characterize pattern use telavancin hospital-based inpatient outpatient infusion center . All treatment decision clinical assessment make discretion treat physician per usual care mandate study design protocol .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Telavancin</mesh_term>
	<criteria>receive least 1 dose telavancin since January 1 , 2015 Participation interventional research study clinical trial involve telavancin January 01 , 2015</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Registry</keyword>
</DOC>